Showing results (211-220 of 3,194) with videos related to
Sort By:
Pageof 320
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)Douglas J Biedenbach, Ronald N JonesDiagnostic Microbiology and Infectious Disease|March 27, 2009
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerationsDouglas J Biedenbach, Ronald N JonesClinics in Podiatric Medicine and Surgery|October 1, 1991
Peripheral vascular assessment and its role in predicting wound healing potentialD N Jones, R B RutherfordDiagnostic Microbiology and Infectious Disease|December 1, 1987
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibitionR N Jones, A L BarryArchives of Pathology & Laboratory Medicine|May 1, 1991
Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American PathologistsR N Jones, D C EdsonThe Journal of Antimicrobial Chemotherapy|November 1, 1988
Interpretative criteria for the agar diffusion susceptibility test with azithromycinA L Barry, R N JonesTranslational Cancer Research|July 11, 2017
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesisMichael I Carr, Stephen N JonesClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococciL M Deshpande, R N JonesThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1992
Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptorsD N Jones, S G HoltzmanDiagnostic Microbiology and Infectious Disease|September 12, 2003
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North AmericaPaul R Rhomberg, Ronald N Jones, Pageof 320